Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Creagan

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
American Journal of Clinical Oncology|April 1, 1982
Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancerJ N Ingle, D L Ahmann, S J Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Cancer Research|November 1, 1986
Phase I trial of parenteral 6-thioguanine given on 5 consecutive daysJ S Kovach, J Rubin, E T Creagan, et al.
American Journal of Clinical Oncology|January 22, 2002
Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancerP D Brown, J A Bonner, R L Foote, et al.
Cancer|December 15, 1984
Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
American Journal of Clinical Oncology|April 1, 1991
Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanomaR F Morton, E T Creagan, D J Schaid, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
American Journal of Clinical Oncology|November 5, 1997
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanomaE T Creagan, K M Rowland, V J Suman, et al.
American Journal of Clinical Oncology|August 1, 1994
Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant diseaseT G Call, E T Creagan, S Frytak, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Oncology|April 1, 1982
Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancerJ N Ingle, D L Ahmann, S J Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1984
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Cancer Research|November 1, 1986
Phase I trial of parenteral 6-thioguanine given on 5 consecutive daysJ S Kovach, J Rubin, E T Creagan, et al.
American Journal of Clinical Oncology|January 22, 2002
Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancerP D Brown, J A Bonner, R L Foote, et al.
Cancer|December 15, 1984
Phase II study of recombinant leukocyte A interferon (rIFN-alpha A) in disseminated malignant melanomaE T Creagan, D L Ahmann, S J Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
A randomized comparative trial of sequential versus alternating cyclophosphamide, doxorubicin, and cisplatin and mitomycin, lomustine, and methotrexate in metastatic non-small-cell lung cancerR T Eagan, S Frytak, R L Richardson, et al.
American Journal of Clinical Oncology|April 1, 1991
Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanomaR F Morton, E T Creagan, D J Schaid, et al.
American Journal of Clinical Oncology|February 1, 1987
Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary reportS Frytak, R T Eagan, R L Richardson, et al.
American Journal of Clinical Oncology|November 5, 1997
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanomaE T Creagan, K M Rowland, V J Suman, et al.
American Journal of Clinical Oncology|August 1, 1994
Phase I trial of combined recombinant interleukin-2 with levamisole in patients with advanced malignant diseaseT G Call, E T Creagan, S Frytak, et al.
Pageof 12